We are live on ! Find out more
FC

FIC Capital Portfolio holdings

AUM $262M
1-Year Est. Return 34.37%
This Fund
S&P 500
This Quarter Est. Return
+11.32%
1 Year Est. Return
+34.37%
3 Year Est. Return
+49.66%
5 Year Est. Return
10 Year Est. Return
AUM
$262M
AUM Growth
+$19.3M
Cap. Flow
-$4.64M
Cap. Flow %
-1.77%
Top 10 Hldgs %
38.33%
Holding
121
New
5
Increased
22
Reduced
60
Closed
2

Sector Composition

Rank Sector Weight
1 Healthcare 22.41%
2 Technology 18.8%
3 Communication Services 14.71%
4 Financials 9.61%
5 Consumer Discretionary 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
T icon
51
AT&T
T
$152B
$1.66M 0.63%
56,241
BNY
52
Bank of New York Mellon
BNY
$108B
$1.63M 0.62%
30,647
+3,775
+14% +$198K
ILMN icon
53
Illumina
ILMN
$28.2B
$1.55M 0.59%
8,001
-565
-7% -$105K
DLTH icon
54
Duluth Holdings
DLTH
$162M
$1.47M 0.56%
72,449
-1,265
-2% -$24.4K
COST icon
55
Costco
COST
$417B
$1.47M 0.56%
8,930
-120
-1% -$18.9K
BIIB icon
56
Biogen
BIIB
$30.4B
$1.4M 0.53%
4,470
-228
-5% -$67.5K
NKE icon
57
Nike
NKE
$64.9B
$1.31M 0.5%
25,279
-140
-0.6% -$7.86K
RTX icon
58
RTX Corp
RTX
$261B
$1.22M 0.46%
16,691
-397
-2% -$29.4K
OXY icon
59
Occidental Petroleum
OXY
$54.6B
$1.19M 0.45%
18,450
-70
-0.4% -$4.26K
AGN
60
DELISTED
Allergan plc
AGN
$1.02M 0.39%
4,996
-151
-3% -$35.1K
IONS icon
61
Ionis Pharmaceuticals
IONS
$8.99B
$978K 0.37%
19,290
HSIC icon
62
Henry Schein
HSIC
$10B
$958K 0.37%
14,905
-548
-4% -$37.4K
LAB icon
63
Standard BioTools
LAB
$350M
$951K 0.36%
188,700
AMGN icon
64
Amgen
AMGN
$198B
$949K 0.36%
5,090
EXPE icon
65
Expedia Group
EXPE
$32.3B
$934K 0.36%
6,489
IPHI
66
DELISTED
INPHI CORPORATION
IPHI
$919K 0.35%
+23,150
New +$867K
SEP
67
DELISTED
Spectra Engy Parters Lp
SEP
$910K 0.35%
20,510
-180
-0.9% -$7.99K
USB icon
68
US Bancorp
USB
$98.4B
$867K 0.33%
16,179
+445
+3% +$23.3K
VV icon
69
Vanguard Large-Cap ETF
VV
$52.2B
$851K 0.32%
7,377
+158
+2% +$17.9K
LBTYA icon
70
Liberty Global Class A
LBTYA
$3.52B
$850K 0.32%
25,078
-7
-0% -$233
VTI icon
71
Vanguard Total Stock Market ETF
VTI
$658B
$814K 0.31%
6,282
-170
-3% -$21.5K
BKR icon
72
Baker Hughes
BKR
$55.5B
$769K 0.29%
+21,010
New +$746K
CRM icon
73
Salesforce
CRM
$140B
$750K 0.29%
8,030
-200
-2% -$18.4K
BAH icon
74
Booz Allen Hamilton
BAH
$7.82B
$734K 0.28%
19,620
-600
-3% -$20.6K
TWX
75
DELISTED
Time Warner Inc
TWX
$695K 0.26%
6,788

Similar funds

FIC Capital's Q3 2017 Portfolio in Review

As of Q3 2017, FIC Capital held 121 positions worth $262M, up 8% from $243M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

FIC Capital's Q3 2017 filing shows 5 new, 22 increased, 60 reduced and 2 closed positions. Its largest new stake was INPHI CORPORATION: 23,150 shares worth $919K. The largest sale was Alnylam Pharmaceuticals, an estimated $1.68M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 20% a quarter earlier, followed by Technology and Communication Services.

  • FIC Capital's largest Q3 2017 buy was INPHI CORPORATION: 23,150 shares worth $919K.
  • FIC Capital added most to Vanguard Short-Term Bond ETF in Q3 2017, an estimated $1.39M increase.
  • FIC Capital's biggest Q3 2017 reduction was Alnylam Pharmaceuticals, cutting an estimated $1.68M.
  • FIC Capital fully exited Rockwell Collins in Q3 2017, selling an estimated $688K.
  • FIC Capital's ten largest holdings make up 38% of its $262M portfolio in Q3 2017.
  • FIC Capital opened 5 new positions and closed 2 in Q3 2017.
  • FIC Capital's portfolio value rose 8% quarter-over-quarter to $262M.

Based on FIC Capital's 13F filing for Q3 2017, filed 14 Nov 2017.